VRIEMPA L 10/5 TABLET
Generic Salt Composition: Empagliflozin 10mg + Linagliptin 5mg
Price: ₹45 MRP: ₹143
Save up to 69% compared to branded medicines.
Top Brand Substitutes & Equivalents
Jardiance Duo, Trajenta Duo, Empagliflozin/Linagliptin, Glyxambi, Empa-Lina, Linaglip-E, Empa-L, Linaglip-M, Empa-Duo, Linaglip-D, Empa-Lin, Linaglip-Plus, Empa-Lina-M, Empa-Lina-D, Empa-Lina-Plus, Empa-Lina-Tab, Empagliflozin Sun Pharma, Sun Pharma Empagliflozin, Empagliflozin Cipla, Cipla Empagliflozin, Empagliflozin Dr Reddys, Dr Reddys Empagliflozin, Empagliflozin Lupin, Lupin Empagliflozin, Empagliflozin Torrent, Torrent Empagliflozin, Empagliflozin Alkem, Alkem Empagliflozin, Empagliflozin Mankind, Mankind Empagliflozin
Product Overview & Uses
VRIEMPA L 10/5 TABLET is a potent oral antidiabetic medication designed for patients struggling with glycemic control in Type 2 Diabetes Mellitus. Classified within the Diabetes Care category, this medication provides a dual-action approach. Empagliflozin works by preventing the kidneys from reabsorbing glucose, allowing it to be excreted through urine, while Linagliptin increases the levels of incretin hormones, which stimulate insulin release and decrease glucagon production. By integrating VRIEMPA L 10/5 TABLET into a comprehensive treatment plan, patients can achieve better long-term blood sugar stability. It is essential that this medication is used alongside diet and exercise modifications to ensure optimal results in the Diabetes Care category.